Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT) -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (311)	7/12/1998 12:23:00 AM
From: Mike	Read Replies (1) \| Respond to of 687

MDT is up solely due to the potential buyout by J&J. I hope this never happens. J&J has shown the market to be very adept at screwing up the implantable medical divisions. In the recent past J&J drove into the ground both it's oxygenator pumps and heart valves prior to selling both to MDT. MDT is finally getting both off the ground and both are doing nicely. J&J has totally and completely screwed up the stent business that they owned. This was a market that is growing at 35-40% and J&J is losing all it's market share. Lets hope for the benefit of MDT that J&J makes a hostile bid for either GDT-Guidant or STJ-St Jude. After that let the history speak for itself and let them drive it into the ground. Ones man's opinion, Mike